Navigation Links
ReBuilder Medical Technologies, Inc. Seeks a Bigger and More Credible Equity Market - 'NASDAQ, here we come!'
Date:4/7/2008

CHARLES TOWN, W.Va., April 7, 2008 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies, Inc. (Pink Sheets: RBRM), President/CEO, David B. Phillips, Ph.D, today announced that the corporation is ready to grow into one of the larger, more efficient, and transparent public equity markets.

(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )

"We have been a publicly held company for a year and have experienced the limitations of being listed only on the Pink Sheets with a large number of shares and a low price per share" said Dr. Phillips. "We have maintained a fully reporting status on Pink Sheets, and are prepared to meet the requirements that the NASDAQ and other markets require. Recent publicity surrounding these small equity markets indicates that without changing the percentage of ownership for our shareholders, we can add value by ensuring our price per share is in line with the larger markets. We do not anticipate offering any new equities, nor do we anticipate using any debt instruments. We are comfortable being a cash company with no receivables and no debt."

"Our next focus will be to evaluate the equity structure of our company to enable us to reach bigger equity markets that can better reflect our credibility. We are reviewing the relevant data and will keep our current investors apprised of our progress," states Dr. Phillips.

For more information visit: http://www.rebuildermedical.com and http://www.molluscum.com.

Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward-looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward-looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words "estimate," "anticipate," "expect," "believe," and similar expressions are intended to be forward-looking statements.


'/>"/>
SOURCE ReBuilder Medical Technologies, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. ReBuilder Medical Technologies, Inc. Reports 1st Quarter 2008 Sales Increase of Over 88%
2. ReBuilder Medical Technologies, Inc. Announces Top Sales Month - $410,000
3. ReBuilder Medical Technologies, Inc. Announces Best Sales Day in 5 Years
4. ReBuilder Medical Technologies, Inc. Announces Revolutionary Electronic Zapper Said to Destroy Molluscum Contagiosum Pathogen
5. ReBuilder Medical Technologies, Inc. Announces 2007 Sales Nearly Doubled Sales in 2006
6. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
7. ReBuilder Medical Technologies, Inc. Announces Televised Broadcast
8. ReBuilder Medical Technologies, Inc. 4th Quarter Sales Increase 100% Exceeding Projections
9. ReBuilder Medical Technologies, Inc. Reports Doubled Profits for October
10. ReBuilder Medical Technologies, Inc. Announces Record Sales Month
11. ReBuilder Medical Technologies, Inc. Celebrates Five Years and 50,000th Shipment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... (PRWEB) , ... February 12, 2016 , ... ... Lean Leadership Series at Zuckerberg San Francisco General Hospital on April 5-7. The ... new behaviors and create new habits. The workshops cover a broad range of ...
(Date:2/12/2016)... NC (PRWEB) , ... February 12, 2016 , ... AssureVest ... surrounding areas, is initiating a charity drive that will raise funds earmarked to purchase ... John C. Tayloe Elementary School. , “My school is in a low-income area and ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... the Pittsburgh metro area, celebrates the beginning of the latest charity campaign in ... social skills through art. Donations to this worthy cause are currently being accepted ...
(Date:2/12/2016)... ... February 12, 2016 , ... J Thomas & Associates ... it’s commitment to act as Agents of Change in the community, announces a ... homeless families to fulfill immediate needs and help them move into permanent housing. ...
(Date:2/12/2016)... ... February 12, 2016 , ... Homeowners ... exterior design possibilities. CertainTeed, North America’s leading brand of building products, has improved ... offerings showcased in the mobile version of the ColorView® Exterior Style and Color ...
Breaking Medicine News(10 mins):
(Date:2/12/2016)... -- Memorial Hermann Health System has teamed up with Houston ... a one-of-a-kind experience to pediatric patients at Children,s ... 360-degree video and Google Cardboard, Howard was able to ... the patients and their families an unexpected, and energetically ... video . Memorial Hermann IRONMAN Sports ...
(Date:2/12/2016)... 12, 2016  Aralez Pharmaceuticals Inc. (Nasdaq: ARLZ ... Company will ring the Nasdaq Closing Bell at the ... at 4:00 p.m. ET on Tuesday, February ... Adrian Adams , will perform the honorary ... 4:00 p.m. ET.  A live webcast will be available ...
(Date:2/12/2016)... 12, 2016 --> ... Chronic Inflammation Global Clinical Trials Review, H2, 2015 ... global clinical trials landscape along with top level ... Country (G7 & E7), Trial Status, Trial Phase, ... top companies involved and enlists all trials (Trial ...
Breaking Medicine Technology: